|
|
|
|
Safety, Efficacy, and Pharmacokinetic Analysis of Glecaprevir/Pibrentasvir in Pediatric Patients With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection: Part 2 of the DORA Study
|
|
|
AASLD 2020 virtual Nov 11-16
Reported by Jules Levin
Maureen M Jonas1, Susan Rhee2, Deirdre A Kelly3, Antonio Del Valle-Segarra4, Cornelia Feiterna-Sperling5, Susan Gilmour6, Regino P Gonzalez-Peralta7, Loreto Hierro8, Daniel H Leung9, Simon C Ling10, Yuri Lobzin11, Steven Lobritto12, Tatsuki Mizuochi13, Michael R Narkewicz14, Vishakha Sabharwal15, Jessica Wen16, Hoi Kei Lon2, John Marcinak2, Andrew Topp2, Rakesh Tripathi2, Etienne Sokal17
1Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States; 2AbbVie Inc., North Chicago, Illinois, United States; 3The Liver Unit, Birmingham Women's & Children's Hospital and University of Birmingham, Birmingham, United Kingdom; 4San Jorge Children's Hospital, San Juan, Puerto Rico; 5Department of Pediatric Pulmonology, Immunology, and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany; 6Stollery Children's Hospital, and University of Alberta, Alberta, Canada; 7AdventHealth for Children and AdventHealth Transplant Institute, Orlando, Florida, United States; 8Hospital Universitario La Paz, Madrid, Spain; 9Division of Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital and Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States; 10Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada; 11Pediatric Research and Clinical Center for Infectious Diseases, Russian Federation; North-Western State Medical University named after I.I. Mechnikov, Russian Federation; St Petersburg, Russia; 12Morgan Stanley Children's Hospital of NY, Columbia University Irving Medical Center, New York, New York, United States; 13Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan; 14Digestive Health Institute, Children's Hospital Colorado, Section of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics University of Colorado School of Medicine, Aurora, Colorado, United States; 15Division of Pediatrics Infectious Diseases, Department of Pediatrics Boston University Medical Center, Boston, Massachusetts, United States; 16The Children's Hospital Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania, United States; 17Université Catholique de Louvain, Cliniques Universitaires Saint Luc, Division of Pediatric Gastroenterology and Hepatology, Brussels, Belgium
|
|
|
|
|
|
|